| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/05/2007 | WO2006026977A3 Polypeptides and method for specifically binding prions |
| 04/05/2007 | WO2006026820A9 Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor |
| 04/05/2007 | WO2006002850A3 OsK1 DERIVATIVES |
| 04/05/2007 | WO2005119899A3 Use of lacritin in promoting ocular cell survival |
| 04/05/2007 | WO2005094453A3 Cospeptin, cosmedin and their uses |
| 04/05/2007 | WO2005072433A3 Toxin induced sympathectomy |
| 04/05/2007 | WO2005056762A3 Truncated cmv promoters and vectors containing same |
| 04/05/2007 | WO2005014780A3 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 04/05/2007 | WO2005000229A3 Compositions and methods for modulating s-nitrosoglutathione reductase |
| 04/05/2007 | WO2004016799A3 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER |
| 04/05/2007 | WO2004014938A3 Thrombopoiesis-stimulating proteins having reduced immunogenicity |
| 04/05/2007 | WO2003070751A3 Partial peptide mimetics and methods |
| 04/05/2007 | WO2003064677A3 Long-acting follicle stimulating hormone analogues and uses thereof |
| 04/05/2007 | US20070079327 System for providing a customized media list |
| 04/05/2007 | US20070078522 Particulate Acellular Tissue Matrix |
| 04/05/2007 | US20070078260 Chemokine panec-2 polynucleotides, polypeptides, antibodies and methods of making and using them |
| 04/05/2007 | US20070078259 Uses of human Zven proteins and polynucleotides |
| 04/05/2007 | US20070078258 Purification process |
| 04/05/2007 | US20070078173 Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 04/05/2007 | US20070078103 Formulations comprising antisense nucleotides to connexins |
| 04/05/2007 | US20070078096 Buffered drug formulations for transdermal electrotransport delivery |
| 04/05/2007 | US20070078095 Compounds and methods for delivery of prostacyclin analogs |
| 04/05/2007 | US20070078094 Guanidinium delivery carriers |
| 04/05/2007 | US20070078093 Methods and compositions for treating cancer |
| 04/05/2007 | US20070078092 Cell permeable conjugates of peptides for inhibition of protein kinases |
| 04/05/2007 | US20070078091 Pharmaceutical combinations for compensating for a testosterone deficiency in men while simultaneously protecting the prostate |
| 04/05/2007 | US20070078090 Anti-chrondrosarcoma compounds |
| 04/05/2007 | US20070078089 Method for effecting changes in the central nervous system by administration of IGF-I or IGF-II |
| 04/05/2007 | US20070078088 Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 10480, 20893, 33230, 1586, 9943, 16334, 68862, 9011, 14031, 6178, 21225, 1420, 32236, 2099, 2150, 26583, 2784, 8941, 9811, 27444, 50566 or 66428 molecules |
| 04/05/2007 | US20070078087 Use of factor VIIa or factor VIIa equivalents for treating trauma |
| 04/05/2007 | US20070078086 Uses of factor VIIa or factor VIIa equivalents for treating late complications of trauma |
| 04/05/2007 | US20070078085 Methods and compositions for the utilization and targeting of osteomimicry |
| 04/05/2007 | US20070078084 Compositions and methods related to production of erythropoietin |
| 04/05/2007 | US20070078083 MODULATION OF NEUORGENESIS BY HDac INHIBITION |
| 04/05/2007 | US20070078082 Methods and compositions to treat glycosaminoglycan-associated molecular interactions |
| 04/05/2007 | US20070078081 Antiviral compounds |
| 04/05/2007 | US20070078080 N4-Acylcytosine Nucleosides for Treatment of Viral Infections |
| 04/05/2007 | US20070078079 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity |
| 04/05/2007 | US20070078078 Core moiety such as 1,4,8,11-tetraazacyclotetradecane with a plurality of side chains containing guanidinium groups; conjugated to antigens, peptides, tumor antigens, anticancer agents, antimicrobials |
| 04/05/2007 | US20070078077 topically administering cyclosporine to an eye of an individual having loss of corneal sensation after refractive surgery on the eye under conditions of at least daily dosing intervals in a therapeutic regimen for a duration sufficient to provide an enhanced rate of restoration of corneal sensitivity |
| 04/05/2007 | US20070078076 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 04/05/2007 | US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 04/05/2007 | US20070077597 Method for identifying modulators of G protein coupled receptor signaling |
| 04/05/2007 | US20070077592 Hemipteran glutamate decarboxylase |
| 04/05/2007 | US20070077590 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds |
| 04/05/2007 | US20070077583 Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance |
| 04/05/2007 | US20070077581 Oncoprotein protein kinase |
| 04/05/2007 | US20070077571 Methods and apparatus for identifying allosterically regulated ribozymes |
| 04/05/2007 | US20070077545 Sperm protective polypeptides and uses thereof |
| 04/05/2007 | US20070077348 Treating with formaldehyde; durability; polyamides, polyurethanes and polyureas as substrates; hydroxymethylation catalysts |
| 04/05/2007 | US20070077292 Compositions and methods for improved skin care |
| 04/05/2007 | US20070077289 Cream containing interferon encapsulated with liposome |
| 04/05/2007 | US20070077283 Method of enhancing transmucosal delivery of therapeutic compounds |
| 04/05/2007 | US20070077274 Method for producing shaped bodies based on crosslinked gelatine |
| 04/05/2007 | US20070077273 Microfabricated nanopore device for sustained release of therapeutic agent |
| 04/05/2007 | US20070077267 Bioactive composite implants |
| 04/05/2007 | US20070077266 Drug/gene eluting stent |
| 04/05/2007 | US20070077258 ADMINISTRATION OF GLUTATHIONE (REDUCED) VIA INTRAVENOUS OR ENCAPSULATED IN LIPOSOME FOR THE AMELIORATION OF TNF-alpha EFFECTS AND FLU-LIKE VIRAL SYMPTOMS AND TREATMENT AND PREVENTION OF VIRUS |
| 04/05/2007 | US20070077251 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 04/05/2007 | US20070077248 Tumour necrosis factor binding ligands |
| 04/05/2007 | US20070077247 Receptor on the surface of activated T-cells: ACT-4 |
| 04/05/2007 | US20070077246 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| 04/05/2007 | US20070077244 Inhibitor protein of the wnt signal pathway |
| 04/05/2007 | US20070077243 Method for making humanized antibodies |
| 04/05/2007 | US20070077239 Peptide carrier for drug delivery |
| 04/05/2007 | US20070077234 Regulation of T cell-mediated immunity by tryptophan |
| 04/05/2007 | US20070077232 Conditioned cell culture medium compositions and methods of use |
| 04/05/2007 | US20070077229 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin |
| 04/05/2007 | US20070077228 Method of treating or retarding the development of blindness |
| 04/05/2007 | US20070077226 Gutless adenovirus vector and the construction method thereof |
| 04/05/2007 | US20070077225 Continuous delivery methods for treating hepatitis virus infection |
| 04/05/2007 | US20070077224 Regulation of T cell-mediated immunity by tryptophan |
| 04/05/2007 | DE112004002847T5 Verwendung von Blutplättchen oder blutblättchenreichem Plasma (PRP) Use of platelets or blood platelet-rich plasma (PRP) |
| 04/05/2007 | CA2664629A1 Oligodendrocyte precursor cell proliferation regulated by prolactin |
| 04/05/2007 | CA2660661A1 Side population cells in cardiac repair |
| 04/05/2007 | CA2625920A1 Analogs of ghrelin |
| 04/05/2007 | CA2624535A1 Hepatocyte growth factor receptor splice variants and methods of using same |
| 04/05/2007 | CA2624498A1 Cd4+ t survivin epitopes and uses thereof |
| 04/05/2007 | CA2624138A1 Method and composition for increasing the engraftment efficiency of stem cells |
| 04/05/2007 | CA2624047A1 Kit for parenteral administration of lipophilic drug solutions |
| 04/05/2007 | CA2623957A1 Compositions for and methods of granzyme b inhibition |
| 04/05/2007 | CA2623635A1 Compositions and methods of using chondroitinase abci mutants |
| 04/05/2007 | CA2623624A1 Variants of the lantibiotic mersacidin and their use |
| 04/05/2007 | CA2623387A1 Use of ephrinb2 directed agents for the treatment or prevention of viral infections |
| 04/05/2007 | CA2623357A1 Inhibitors of ste20-like kinase (slk) and methods of modulating cell cycle progression and cell motility |
| 04/05/2007 | CA2622915A1 Calcium binding peptides |
| 04/05/2007 | CA2621623A1 Il-17a and il-17f antagonists and methods of using the same |
| 04/05/2007 | CA2620051A1 Method for enhancing effects of colorants and conditioners |
| 04/05/2007 | CA2618068A1 Stable aqueous protein or antibody pharmaceutical formulations and their preparation |
| 04/05/2007 | CA2590401A1 Adoptive immunotherapy with enhanced t lymphocyte survival |
| 04/04/2007 | EP1770397A1 Procalcitonin 3-116 |
| 04/04/2007 | EP1770164A2 Streptococcus pneumoniae antigens and vaccines |
| 04/04/2007 | EP1770163A2 Antagonists of interleukin-15 |
| 04/04/2007 | EP1770162A1 Immunological compositions to modulate myostatin in vertebrate subjects |
| 04/04/2007 | EP1770161A2 BMP-11 compositions |
| 04/04/2007 | EP1770159A1 Process for manufacturing a pharmaceutical composition for treating diabetes |
| 04/04/2007 | EP1770100A2 Transferrin receptor genes of Moraxella |
| 04/04/2007 | EP1770099A1 Method of producing a modified (poly)peptide |
| 04/04/2007 | EP1769807A1 Graft rejection suppressors |
| 04/04/2007 | EP1769805A1 Therapeutic modulation of the tumor inflammatory response |